Noha Ibrahim | Neuroplacentology | Best Researcher Award

Dr. Noha Ibrahim | Neuroplacentology | Best Researcher Award

Dr. Noha Ibrahim, HSE, Ireland.

Noha Ibrahim’s journey from her early academic excellence to becoming a leading psychiatrist reflects her dedication to medicine and mental health. Her extensive experience across multiple psychiatric subspecialties, coupled with her commitment to research and education, has made a significant impact in the field. Her expertise in neuropsychiatry and autism spectrum disorders, along with her contributions to psychotherapy and mental health advocacy, highlights her influential role in psychiatric care.

Profile

Orcid

✨ Early Academic Pursuits ✨

Noha Ibrahim’s academic journey began at Khartoum International Preparatory School (KIPS), Sudan, where she laid the foundation for her future in medicine. Demonstrating exceptional promise, she pursued her undergraduate studies at the National Ribat University in Khartoum, earning her Medicine and Surgery Bachelor’s Degree in 2008. During her studies, her dedication to research and academic excellence was recognized when she was awarded the Best National Medical Student Research accolade in 2007. This early recognition highlighted her potential and set the stage for an impactful career in psychiatry.

🏥 Professional Endeavors 🏥

With over 11 years of experience in psychiatry, Noha Ibrahim has contributed significantly to multiple subspecialties, including General Adult Psychiatry, Liaison Psychiatry, Addiction Psychiatry, Child and Adolescent Mental Health Services (CAMHS), Rehabilitation, Intellectual Disability, Neuropsychiatry, and Adult ADHD. Her rigorous training led her to achieve the Certificate of Satisfactory Completion of Specialist Training (CSCST) in General Adult Psychiatry with a focus on academic neuropsychiatry in January 2024 from the College of Psychiatry in Ireland (COPI). Noha’s professional journey reflects her unwavering commitment to advancing mental health care through clinical expertise and continuous learning.

📚 Contributions and Research Focus 📚

Throughout her career, Noha Ibrahim has remained actively engaged in research and clinical education. Her passion for academia led her to complete a Postgraduate Diploma in Health Sciences in 2022, followed by a Master’s in Clinical Education at the University of Galway in 2023. She has been extensively trained in Autism Diagnostic Observation Schedule (ADOS) since 2020 and Autism Clinical Interview for Adults (ACIA) in 2024. Noha’s research interests focus on neuropsychiatry, autism spectrum disorders, and the application of structured therapeutic models in clinical practice, ensuring that her contributions extend beyond patient care into shaping the future of psychiatric education and training.

🏆 Accolades and Recognition 🏆

Recognized for her excellence in both clinical and academic psychiatry, Noha Ibrahim has achieved multiple prestigious memberships and registrations. She has been a Member of the College of Psychiatrists of Ireland (MCPsychI) since 2020, an active member of the Irish Medical Council since 2013, and has maintained her Sudanese Medical Council registration since 2008. Her research excellence was acknowledged as early as 2007 when she was honored as the Best National Medical Student Researcher, an award that emphasized her dedication to advancing medical knowledge.

🧠 Impact and Influence 🧠

Beyond her clinical practice, Noha Ibrahim has played an instrumental role in advancing mental health awareness and education. She has provided psychotherapy using Cognitive Analytical Therapy (CAT) and Cognitive Behavioral Therapy (CBT) to patients with complex psychiatric needs. Additionally, her commitment to community mental health was evident when she facilitated Deciders Skills courses for teenagers in CAMHS, Co. Clare, in 2016, equipping young individuals with essential coping strategies. Her dedication to patient-centered care and education has made a lasting impact on both her colleagues and the patients she serves.

📝 Legacy and Future Contributions 📝

As a distinguished professional in the field of psychiatry, Noha Ibrahim continues to shape the future of mental health services through her expertise and research. With her extensive experience in neuropsychiatry and autism spectrum disorders, she aims to further develop specialized diagnostic and therapeutic approaches that can enhance patient care. Her contributions to psychiatric education and training will leave a lasting legacy, inspiring future generations of mental health professionals. With her dual Sudanese-Irish background, Noha represents a bridge between diverse medical communities, fostering collaboration and innovation in the field of psychiatry.

 

Publication

Title: Examining the association between placental malperfusion assessed by histopathological examination and child and adolescent neurodevelopment: a systematic review
Author(s): Noha Ibrahim, Sydni A. Weissgold, Lucy Brink, Ibtihal Mahgoub, Benjamin Richard Carter, Vaheshta Sethna, Hein Odendaal
Year: 2025

 

💪 Conclusion 💪

Through years of dedication, clinical expertise, and research, Noha Ibrahim has established herself as a highly respected psychiatrist and educator. Her impact on mental health care, particularly in neuropsychiatry, is profound, and her future contributions will continue to shape the landscape of psychiatric education and patient care. With her unwavering commitment to innovation and compassionate care, she remains a driving force in advancing the field of psychiatry for years to come.

 

Ketan Bulsara | Cellular Neuroscience | Excellence in Neuroscience Research Award

Dr. Ketan Bulsara | Cellular Neuroscience | Excellence in Neuroscience Research Award

Dr. Ketan Bulsara, University of Connecticut, United States.

Dr. Ketan Ramanlal Bulsara is a distinguished neurosurgeon, educator, and administrator whose career has been defined by excellence in academic leadership, innovative research, and patient-centered surgical advancements. With a strong foundation in medical education and training, he has held prestigious positions at leading institutions, making significant contributions to the fields of cerebrovascular and skull base surgery. His work in neurosurgical education, healthcare policy, and perioperative quality improvement continues to influence the next generation of medical professionals.

Profile

Google Scholar

 

🎓 Early Academic Pursuits: The Foundation of Excellence

Dr. Ketan Ramanlal Bulsara’s journey into the world of neurosurgery began with a strong academic foundation. He earned his Bachelor of Science in Biology and Neuroscience, graduating Magna Cum Laude from Davidson College in 1992. His passion for medicine led him to Duke University School of Medicine, where he earned his Medical Degree with Honors in 1996. Committed to mastering his craft, Dr. Bulsara underwent rigorous neurosurgical training at Duke University Medical Center, progressing through internship, residency, and chief residency roles. His dedication to specialized knowledge took him to the University of Iowa for a fellowship in Transoral Surgery and later to Duke’s Neurovascular Program for an advanced Endovascular Fellowship, earning CAST certification by the Senior Neurological Society.

🎉 Professional Endeavors: Pioneering Neurosurgical Excellence

Dr. Bulsara has held esteemed academic and leadership positions throughout his career. Beginning as an Assistant Professor at the University of Missouri, he quickly ascended to directorship roles at Yale University, where he led Neuroendovascular and Skull Base Surgery Programs. His expertise and leadership took him to UConn Health, where he has served as Professor and Chief of Neurosurgery since 2017. As Program Director of UConn’s Neurosurgery Residency Training Program and Director of Operating Room Quality, he has been instrumental in shaping the next generation of neurosurgeons. His administrative impact extended further when he was appointed Interim Inaugural Chairman of UConn’s Department of Neurosurgery in 2024.

📚 Contributions and Research Focus: Advancing Neurosurgical Innovation

Throughout his career, Dr. Bulsara has been at the forefront of neurosurgical research, focusing on cerebrovascular and skull base surgery, neuroendovascular techniques, and perioperative advancements. His tenure at Yale and UConn Health has been marked by groundbreaking contributions to neurosurgical methodologies, patient safety protocols, and cutting-edge surgical interventions. With a keen interest in medical policy and administration, he also serves as Chair of the UConn Health/University of Connecticut Dean’s Task Force on Coding and Documentation, ensuring optimal standards in medical practice.

🏆 Accolades and Recognition: A Trailblazer’s Achievements

Dr. Bulsara’s exemplary work has earned him widespread recognition in academic, clinical, and administrative spheres. His leadership has been pivotal in strengthening neurosurgical departments and residency programs, earning respect from peers and students alike. His continued commitment to excellence led him to pursue an Executive MBA at Yale School of Management, which he completed in 2017, equipping him with advanced skills in healthcare management and strategic planning. Furthering his multidisciplinary expertise, he embarked on a legal education at the University of Connecticut School of Law in 2024, highlighting his commitment to integrating medicine, business, and law for the betterment of healthcare.

💡 Impact and Influence: Shaping the Future of Neurosurgery

Dr. Bulsara’s influence extends far beyond the operating room. As a mentor, he has trained and guided numerous neurosurgeons, instilling in them the values of precision, innovation, and patient-centered care. His research and administrative contributions have shaped hospital policies and perioperative strategies, leading to improved surgical outcomes and enhanced healthcare delivery systems. His work in academic leadership continues to bridge the gap between medical practice, research, and education.

 

Publication

  • Spinal axon regeneration evoked by replacing two growth cone proteins in adult neurons – HM Bomze, KR Bulsara, BJ Iskandar, P Caroni, JH Pate Skene (2001)

 

  • Longitudinal molecular trajectories of diffuse glioma in adults – FP Barthel, KC Johnson, FS Varn, AD Moskalik, G Tanner, E Kocakavuk, et al. (2019)

 

  • Glioma progression is shaped by genetic evolution and microenvironment interactions – FS Varn, KC Johnson, J Martinek, JT Huse, MLP Nasrallah, P Wesseling, et al. (2022)

 

  • Accuracy of prediction instruments for diagnosing large vessel occlusion in individuals with suspected stroke: a systematic review for the 2018 guidelines for the early… – EE Smith, DM Kent, KR Bulsara, LY Leung, JH Lichtman, MJ Reeves, et al. (2018)

 

  • Perioperative complications in transforaminal lumbar interbody fusion versus anterior–posterior reconstruction for lumbar disc degeneration and instability – AT Villavicencio, S Burneikiene, KR Bulsara, JJ Thramann (2006)

 

  • Vessel wall magnetic resonance imaging identifies the site of rupture in patients with multiple intracranial aneurysms: proof of principle – CC Matouk, DM Mandell, M Günel, KR Bulsara, A Malhotra, R Hebert, et al. (2013)

 

  • Safety of transforaminal lumbar interbody fusion and intervertebral recombinant human bone morphogenetic protein—2 – AT Villavicencio, S Burneikiene, EL Nelson, KR Bulsara, M Favors, et al. (2005)

 

  • Laminectomy versus percutaneous electrode placement for spinal cord stimulation – AT Villavicencio, JC Leveque, L Rubin, K Bulsara, JP Gorecki (2000)

 

  • Indications for thrombectomy in acute ischemic stroke from emergent large vessel occlusion (ELVO): report of the SNIS Standards and Guidelines Committee – M Mokin, SA Ansari, RA McTaggart, KR Bulsara, M Goyal, M Chen, et al. (2019)

 

  • Review of the literature on de novo formation of cavernous malformations of the central nervous system after radiation therapy – SM Nimjee, CJ Powers, KR Bulsara (2006)

 

💪 Conclusion

A visionary in neurosurgery, Dr. Bulsara’s impact transcends surgical practice, reaching into medical education, research, and healthcare administration. His multidisciplinary approach—combining medicine, business, and law—positions him as a leader in shaping the future of healthcare. His commitment to innovation and excellence ensures that his contributions will continue to elevate neurosurgical standards and inspire future generations of medical professionals.

 

 

 

Rita Abi Rached | Neuropharmacology | Best Researcher Award

Dr. Rita Abi Rached | Neuropharmacology | Best Researcher Award

Dr. Rita Abi Rached, University of Cagliari, Italy.

Rita Joseph Abi Rached has built a remarkable career at the intersection of food chemistry, biochemistry, and sustainability. From her foundational academic journey to her current research in agri-food by-product valorization, she has continuously sought innovative solutions to environmental and health-related challenges. Her expertise spans industry collaborations, cutting-edge research, and impactful scientific contributions, making her a leading figure in sustainable food science.

Profile

Google Scholar

Early Academic Pursuits – A Passion for Science

From an early age, Rita Joseph Abi Rached demonstrated an innate curiosity for the sciences, particularly in the fields of biochemistry and food chemistry. She embarked on her academic journey with a Bachelor’s degree in Biochemistry from Saint Joseph University of Beirut in 2017, where she cultivated a strong foundation in molecular sciences. Her passion for the chemical intricacies of food systems led her to pursue a Master’s degree in Food Chemistry in 2019, further refining her expertise in the biochemical properties of agro-food products. This academic dedication ultimately culminated in a Double Ph.D. in Life, Environmental, and Pharmaceutical Sciences from the University of Cagliari and Saint Joseph University of Beirut in 2024, marking a significant milestone in her scholarly endeavors.

🌱 Professional Endeavors – Bridging Academia and Industry 🌱

With an unwavering commitment to research, Rita transitioned from academia to professional scientific exploration. Her early training included hands-on experiences at Château Ksara, where she assessed grape phenolic maturity, and at Libby’s, where she gained insights into quality control and microbiological analyses. Further strengthening her industrial expertise, she worked as a lab researcher and research assistant at Saint Joseph University, refining her skills in polyphenol analysis and microbiological assessments. These experiences not only expanded her technical competencies but also paved the way for her role as a dedicated researcher at the University of Cagliari, where she currently investigates sustainable approaches to agri-food by-product valorization.

🤝 Contributions and Research Focus – Innovating for a Sustainable Future 🤝

Rita’s research is deeply rooted in sustainability and the innovative utilization of agricultural and industrial biomasses. Her current work revolves around the valorization of agro-industrial by-products, transforming waste into functional bioactive compounds for health and agriculture. She has actively contributed to groundbreaking projects such as BESTMEDGRAPE, which applied nanotechnological strategies to enhance Mediterranean grape derivatives, and MEDLENTISK, an Erasmus+ initiative that explored best practices for mastic tree fixed oil. Additionally, she played a pivotal role in TECNOCOVID, a project leveraging natural bioactives and nanotechnologies to combat COVID-19. Her most recent endeavor, NUTRINNOVA, focuses on utilizing nutriosomes derived from agro-industrial waste to mitigate dysbiosis, oxidative stress, and cognitive decline, further establishing her as a pioneer in sustainable food research.

🏆 Accolades and Recognition – A Scholar’s Journey 🏆

Throughout her career, Rita has garnered significant recognition for her impactful contributions to scientific research. Her work has been widely cited, with a citation index of 72 and an h-index of 4, reflecting her influence in the academic community. These achievements underscore the relevance of her studies in the fields of food science, biotechnology, and environmental sustainability. Her research outputs continue to inspire new approaches to the responsible and efficient use of natural resources, positioning her as a respected voice in her domain.

🔍 Impact and Influence – Shaping the Scientific Landscape 🔍

As an advocate for innovative and sustainable research, Rita’s work has transcended the boundaries of traditional food science, merging interdisciplinary methodologies to address global challenges. By focusing on agri-food waste valorization, she has provided meaningful insights into reducing environmental impact while enhancing the nutritional and therapeutic value of food by-products. Her collaborations with industry leaders and academic institutions have reinforced her reputation as a key contributor to cutting-edge scientific advancements.

 

Publication

  • Title: Entrapment of Citrus limon var. pompia Essential Oil or Pure Citral in Liposomes Tailored as Mouthwash for the Treatment of Oral Cavity Diseases
    Author(s): L Palmas, M Aroffu, GL Petretto, E Escribano-Ferrer, O Díez-Sales, …
    Year: 2020

 

  • Title: Extraction, Characterization and Incorporation of Hypericum scruglii Extract in Ad Hoc Formulated Phospholipid Vesicles Designed for the Treatment of Skin
    Author(s): M Allaw, M Manconi, M Aroffu, F Marongiu, M Porceddu, G Bacchetta, …
    Year: 2020

 

  • Title: Optimization of Polyphenols Extraction from Purple Corn Cobs Using ß-Cyclodextrin as a Green Solvent
    Author(s): HN Rajha, S Khabbaz, R Abi Rached, E Debs, RG Maroun, N Louka
    Year: 2020

 

  • Title: From Grape By-Products to Enriched Yogurt Containing Pomace Extract Loaded in Nanotechnological Nutriosomes Tailored for Promoting Gastro-Intestinal Wellness
    Author(s): I Castangia, F Fulgheri, FJ Leyva-Jimenez, ME Alañón, ML Cádiz-Gurrea, …
    Year: 2023

 

  • Title: From Field to Waste Valorization: A Preliminary Study Exploring the Impact of the Wine Supply Chain on the Phenolic Profile of Three Sardinian Pomace Extracts
    Author(s): I Castangia, M Aroffu, F Fulgheri, R Abi Rached, F Corrias, G Sarais, …
    Year: 2024

 

  • Title: Innovation in Cannon Puffing Technology for the Homogenization of Bulk Treatment: Half‐Popped Purple Corn, a New Healthy Snack
    Author(s): HN Rajha, E Debs, R Abi Rached, K El Khoury, M Al‐Kazzi, R Mrad, …
    Year: 2021

 

  • Title: Exploring the Efficacy and Industrial Potential of Polyphenol Products from Grapes and Their By-Products
    Author(s): R Abi Rached, M Perra, ML Manca, HN Rajha, N Louka, RG Maroun, …
    Year: 2024

 

  • Title: A Preliminary Investigation on Hydrogel Disks Imbibed with Enriched Transfersomes as a Promising Tool to Promote the Cutaneous Deposition of Vaccine Antigens
    Author(s): M Aroffu, R Abi Rached, I Castangia, P Italiani, L D’Apice, …
    Year: 2024

 

  • Title: Preliminary Evaluation of the In Vitro and In Vivo Efficacy of a Novel Nanovesicle-Doped Nanoemulsion Co-Loading Artemisinin and Quercetin as a Promising Strategy to Improve …
    Author(s): F Fulgheri, M Ramírez, L Román-Álamo, P Gasco, M Manconi, M Aroffu, …
    Year: 2025

 

  • Title: Clinical Trial to Evaluate the Effect of Grape Seed Extract-Loaded Hyalurosomes on Skin Wellness
    Author(s): RA Rached, M Habre, Y Salem, J Khodeir, M Allaw, I Castangia, …
    Year: 2025

 

🔗 Conclusion 🔗

With an unwavering passion for science and an unrelenting drive for discovery, Rita Joseph Abi Rached stands as a beacon of innovation, inspiring future generations to embrace sustainability, research, and the transformative power of science. Her legacy in food science and biochemistry will continue to shape the future of sustainable research, leaving a lasting impact on both academia and industry.

Daša Zupančič | Cellular Neuroscience | Best Researcher Award

Assoc. Prof. Dr. Daša Zupančič | Cellular Neuroscience | Best Researcher Award

Assoc. Prof. Dr. Daša Zupančič, Faculty of Medicine, University of Ljubljana, Slovenia.

Daša Zupančič is a distinguished academic and researcher specializing in cell biology, urothelial pathology, and medical education. Her extensive contributions to scientific research, particularly in the field of urothelial repair and cancer transformation, have earned her recognition, including the EMBO award. She has played a crucial role in mentoring and teaching, guiding future generations of researchers and medical professionals.

Profile

Orcid

✨ Early Academic Pursuits ✨

Daša Zupančič embarked on her academic journey with an unwavering passion for cell biology and medicine. She earned her Master’s degree in 2002 from the University of Ljubljana, Faculty of Medicine, where she meticulously explored cellular and molecular biological changes in the rat bladder urothelium following cyclophosphamide exposure. This formative research laid the foundation for her Ph.D., which she successfully completed in 2006, investigating the protective role of melatonin in urothelial injury and repair. Her dedication to advancing biomedical knowledge was evident from the very beginning of her scholarly career.

🎓 Professional Endeavors 🎓

Since 2006, Daša Zupančič has been an esteemed Associate Professor at the University of Ljubljana, Faculty of Medicine, Institute of Cell Biology. Prior to this, she gained valuable experience as a Young Researcher and Teaching Assistant from 1999 to 2006. Her extensive expertise and commitment to education have made her an integral part of the institution, where she continuously fosters scientific curiosity and excellence among students and colleagues alike.

🎡 Contributions and Research Focus 🎡

Throughout her career, Daša Zupančič has dedicated her research to understanding cellular mechanisms in urothelial biology and pathology. Her investigations into cyclophosphamide-induced urothelial injury, melatonin’s protective effects, and retinoid signaling pathways in urothelial cancer transformation have provided valuable insights into cellular repair processes. Her work extends beyond laboratory research, influencing the medical community’s approach to urothelial diseases and potential therapeutic advancements.

🏆 Accolades and Recognition 🏆

Her exceptional contributions to biomedical research have been recognized on multiple platforms. In 2017, she was honored with the prestigious EMBO award for her short-term scholarship project on the role of the retinoid signaling pathway in urothelial cancer transformation. This recognition underscores her significant impact on the scientific community and highlights her pioneering approach to understanding cancer pathophysiology.

👨‍🎓 Impact and Influence 👨‍🎓

A dedicated mentor, Daša Zupančič has guided numerous students towards academic excellence. Between 2014 and 2025, she has successfully mentored four master’s students and is currently supervising two more. In addition, she has overseen the research endeavors of four Ph.D. candidates, with one having successfully defended their dissertation in 2023 and another expected to graduate in 2025. Her mentorship has shaped the next generation of biomedical researchers, fostering a culture of rigorous inquiry and scientific discovery.

📚 Legacy and Future Contributions 📚

Beyond her research, Daša Zupančič plays a pivotal role in academia through her extensive teaching engagements. Since 2000, she has been a cornerstone of education at the University of Ljubljana, contributing to multiple faculties, including Medicine, Biotechnical Sciences, Health Sciences, and Pharmacy. She teaches a range of graduate and doctoral courses, covering essential subjects such as Medical Cell Biology, Immunology, and Research in Medicine. Her dedication to education ensures that her knowledge and expertise continue to shape the minds of aspiring medical professionals and researchers for years to come.

Publication

  • Vitamin A‐Enriched Diet Increases Urothelial Cell Proliferation by Upregulating Itga3 and Areg After Cyclophosphamide‐Induced Injury in Mice
    Authors: Brina Dragar, Simona Kranjc Brezar, Maja Čemažar, Tanja Jesenko, Rok Romih, Mateja Erdani Kreft, Tadeja Kuret, Daša Zupančič
    Year: 2025

 

  • Selective Targeting of Lectins and Their Macropinocytosis in Urothelial Tumours: Translation from in vitro to ex vivo
    Authors: Nataša Resnik, Tanja Višnjar, Tomaž Smrkolj, Mateja Erdani Kreft, Rok Romih, Daša Zupančič
    Year: 2023

 

  • Nanodiamonds as Possible Tools for Improved Management of Bladder Cancer and Bacterial Cystitis
    Authors: Daša Zupančič, Peter Veranič
    Year: 2022

 

  • Transmission Electron Microscopy Demonstration of Reduced Endothelial Glycocalyx in Severe Preeclampsia
    Authors: Mugerli S, Zupančič D, Rok Romih, Lučovnik M
    Year: 2022

 

  • Vitamin A and Retinoids in Bladder Cancer Chemoprevention and Treatment: A Narrative Review of Current Evidence, Challenges and Future Prospects
    Authors: Larisa Tratnjek, Jera Jeruc, Rok Romih, Daša Zupančič
    Year: 2021

 

  • Immunohistochemistry as a Paramount Tool in Research of Normal Urothelium, Bladder Cancer and Bladder Pain Syndrome
    Authors: Daša Zupančič, Rok Romih
    Year: 2021

 

  • Combined Lectin- and Immuno-Histochemistry (CLIH) for Applications in Cell Biology and Cancer Diagnosis: Analysis of Human Urothelial Carcinomas
    Authors: Daša Zupančič
    Year: 2020

 

  • Vitamin A Rich Diet Diminishes Early Urothelial Carcinogenesis by Altering Retinoic Acid Signaling
    Authors: Daša Zupančič, Jelena Korać-Prlić, Mateja Erdani Kreft, Lucija Franković, Katarina Vilović, Jera Jeruc, Rok Romih, Janoš Terzić
    Year: 2020

 

  • Lectins as Possible Tools for Improved Urinary Bladder Cancer Management
    Authors: Daša Zupančič
    Year: 2019

 

  • Co-Culturing Porcine Normal Urothelial Cells, Urinary Bladder Fibroblasts and Smooth Muscle Cells for Tissue Engineering Research
    Authors: Daša Zupančič
    Year: 2018

 

🌟 Conclusion 🌟

With a career dedicated to pioneering research, impactful mentorship, and transformative education, Daša Zupančič continues to leave a lasting legacy in the scientific and academic communities. Her work not only enhances understanding of urothelial biology but also inspires innovation and discovery among young scientists. As she continues her academic and research endeavors, her influence on the field will undoubtedly grow, shaping the future of biomedical sciences.

 

Zhong Suyu | Neuroimaging | Best Researcher Award

Assoc. Prof. Dr. Zhong Suyu | Neuroimaging | Best Researcher Award

Assoc. Prof. Dr. Zhong Suyu, Beijing University of Posts and Telecommunications, China.

Zhong Suyu is a distinguished scholar at the intersection of artificial intelligence and cognitive neuroscience. With an academic foundation in biomedical engineering and a Ph.D. in Cognitive Neuroscience from Beijing Normal University, they have dedicated their career to exploring AI-driven brain research. Their postdoctoral work and current role as an Associate Professor at the Beijing University of Posts and Telecommunications have positioned them as a leading expert in brain-computer interfaces, neural signal processing, and machine learning applications in cognitive studies. Through groundbreaking research, impactful publications, and mentorship, they continue to shape the future of AI-integrated neuroscience.

Profile

Google Scholar

Early Academic Pursuits 🎓

Zhong Suyu’s academic journey began with a deep-rooted passion for the intersection of medicine, engineering, and neuroscience. They earned a Bachelor’s degree in Biomedical Engineering from Capital Medical University in 2006, laying the groundwork for their future research. Eager to expand their expertise, they pursued a Master’s degree at Beijing University of Aeronautics and Astronautics, delving further into biomedical engineering and honing their skills in medical technology. The pinnacle of their academic training came with a Ph.D. in Cognitive Neuroscience from Beijing Normal University in 2016, where they explored the intricate relationship between human cognition and artificial intelligence.

Professional Endeavors 🏛️

Following the completion of their doctorate, Zhong Suyu embarked on an enriching postdoctoral journey at Beijing Normal University from 2016 to 2020. This period was instrumental in refining their research focus and contributing to groundbreaking studies. Their commitment to academic excellence led them to Beijing University of Posts and Telecommunications, where they assumed the role of Associate Professor in the School of Artificial Intelligence in 2023. In this capacity, they have been at the forefront of AI-driven neuroscience, guiding students and conducting pioneering research in the field.

Contributions and Research Focus 🔬

At the heart of Zhong Suyu’s work lies an innovative approach to integrating artificial intelligence with cognitive neuroscience. Their research explores brain-computer interfaces, neural signal processing, and machine learning applications in cognitive studies. By bridging AI with human cognition, they aim to unlock new possibilities in medical diagnostics, brain function analysis, and human-machine interaction. Their interdisciplinary contributions have positioned them as a thought leader in the evolution of AI-driven neurological studies.

Accolades and Recognition 🏆

Zhong Suyu’s dedication to research and education has earned them notable recognition in the scientific community. Their work has been published in prestigious journals, and they have been invited to speak at international conferences on artificial intelligence and neuroscience. Whether through peer-reviewed studies or academic symposiums, their influence continues to grow, marking them as a distinguished scholar in their domain.

Impact and Influence 🌍

Beyond academic circles, Zhong Suyu’s research has profound real-world applications. Their insights into AI-powered cognitive analysis have the potential to revolutionize mental health assessments, neurological disorder treatments, and adaptive learning systems. As an educator, they inspire a new generation of researchers, fostering curiosity and innovation among students eager to explore the vast possibilities of AI and neuroscience.

Legacy and Future Contributions 🚀

With an unwavering commitment to advancing artificial intelligence and cognitive science, Zhong Suyu’s legacy is one of transformation and discovery. As they continue to push the boundaries of human-machine integration, their future research is poised to shape the next era of intelligent systems. Through continued collaborations, technological advancements, and mentorship, they remain a driving force in redefining the synergy between artificial intelligence and the human brain.

Publication

  1. PANDA: a pipeline toolbox for analyzing brain diffusion images
    Z Cui, S Zhong, P Xu, Y He, G Gong2013

 

  1. Developmental changes in topological asymmetry between hemispheric brain white matter networks from adolescence to young adulthood
    S Zhong, Y He, H Shu, G Gong2017

 

  1. The abnormality of topological asymmetry between hemispheric brain white matter networks in Alzheimer’s disease and mild cognitive impairment
    C Yang, S Zhong, X Zhou, L Wei, L Wang, S Nie2017

 

  1. A significant risk factor for poststroke depression: the depression-related subnetwork
    S Yang, P Hua, X Shang, Z Cui, S Zhong, G Gong, GW Humphreys2015

 

  1. Convergence and divergence across construction methods for human brain white matter networks: an assessment based on individual differences
    S Zhong, Y He, G Gong2015

 

  1. The white matter structural network underlying human tool use and tool understanding
    Y Bi, Z Han, S Zhong, Y Ma, G Gong, R Huang, L Song, Y Fang, Y He2015

 

  1. Deficiency of brain structural sub‐network underlying post‐ischaemic stroke apathy
    S Yang, P Hua, X Shang, Z Cui, S Zhong, G Gong, G William Humphreys2015

 

  1. The semantic anatomical network: Evidence from healthy and brain‐damaged patient populations
    Y Fang, Z Han, S Zhong, G Gong, L Song, F Liu, R Huang, X Du, R Sun2015

 

Conclusion 🌟

Zhong Suyu’s journey is a testament to the power of interdisciplinary research in advancing both artificial intelligence and human cognition. Their work not only contributes to academic knowledge but also has the potential to revolutionize medical diagnostics, mental health assessments, and human-machine interactions. As they continue to push the frontiers of AI and neuroscience, their legacy will inspire future researchers and redefine the possibilities of intelligent systems in cognitive sciences.

Pongrama Ramasoota | Molecular and Cellular Neuroscience | Best Researcher Award

Prof. Dr. Pongrama Ramasoota | Molecular and Cellular Neuroscience | Best Researcher Award

Prof. Dr. Pongrama Ramasoota, Mahidol University, Thailand.

Dr. Pongrama Ramasoota is a distinguished professor and researcher specializing in antibody research and virology at the Centre of Excellence for Antibody Research (CEAR), Mahidol University, Thailand. With a strong academic foundation in veterinary medicine, public health, and microbiology, he has dedicated his career to developing therapeutic and diagnostic monoclonal antibodies against viruses such as Dengue, Rabies, Foot and Mouth Disease, and Influenza. His contributions extend beyond infectious disease research, as he has also explored anti-aging supplements for humans and pets. Recognized with numerous national and international awards, his research has significantly impacted medical biotechnology, earning him a reputation as a leading scientist in his field.

 

Profile

Scopus

 

🎓 Early Academic Pursuits

Pongrama Ramasoota’s journey into the world of microbiology and antibody research began with a solid foundation in veterinary medicine. He earned his Doctor of Veterinary Medicine from Kasetsart University, where his fascination with infectious diseases and immunology took root. His academic pursuits led him to Mahidol University, where he obtained a Master of Public Health, further broadening his expertise in disease prevention and control. Driven by a passion for scientific exploration, he pursued a Master of Science and Ph.D. in Microbiology at the prestigious Swedish University of Agricultural Sciences in Uppsala, Sweden. These formative years were instrumental in shaping his career as a leading researcher in antibody development and disease management.

🏥 Professional Endeavors

As a distinguished professor at the Centre of Excellence for Antibody Research (CEAR) within the Faculty of Tropical Medicine, Mahidol University, Dr. Ramasoota has dedicated his career to advancing the field of immunotherapy. His research primarily focuses on developing neutralizing monoclonal antibodies to combat viral threats such as Dengue and Rabies. Over the years, he has led groundbreaking projects aimed at creating effective therapeutic and diagnostic solutions. His expertise has also extended beyond academia, as he collaborates with industry leaders to translate research into practical applications that benefit global health.

🦠 Contributions and Research Focus

Dr. Ramasoota’s contributions to medical research are vast and impactful. His work on neutralizing human monoclonal antibodies against Dengue and Rabies viruses has paved the way for potential life-saving treatments. His research extends to diagnostic monoclonal antibodies for detecting Foot and Mouth Disease Virus (FMDV) and Influenza, significantly enhancing disease surveillance. Beyond infectious diseases, he has also ventured into anti-aging research, developing natural supplements to promote longevity in both humans and pets. His relentless pursuit of innovation continues to drive advancements in virology, immunotherapy, and biotechnology.

🏆 Accolades and Recognition

Dr. Ramasoota’s contributions to science have been recognized with numerous prestigious awards. He was honored as Thailand’s Outstanding Researcher in 2020 and named Thailand’s Outstanding Veterinarian in 2016. His innovative work earned him multiple Outstanding Research and Invention Awards from the National Research Council of Thailand between 2008 and 2016. He has also received international recognition, including a gold medal from the 2014 Taipei Invention & Techno Mart and awards from the Korea Invention Association and the International Federation of Inventors’ Associations. These accolades underscore his influence as a pioneer in antibody research and biotechnology.

🌍 Impact and Influence

With an H-index of 18 and over 1,038 citations on Scopus, Dr. Ramasoota’s research has significantly influenced the scientific community. His findings have been instrumental in shaping new treatment strategies for viral diseases, providing hope for better therapeutic interventions. Collaborating with industry leaders such as Advy Chemical (India) and Thai-Naoka (Thailand), he has helped bridge the gap between research and real-world applications. His contributions to diagnostic tools and monoclonal antibody therapies continue to shape the future of virology and medical biotechnology.

📚 Legacy and Future Contributions

Beyond his research endeavors, Dr. Ramasoota has authored books that highlight his expertise in environmental management and anti-aging technologies. His book Hallmarks of Aging, Technology and Innovation for Anti-Aging explores groundbreaking advancements in longevity research, demonstrating his commitment to improving human health across various dimensions. As he continues to innovate, his legacy as a leading researcher in antibody development and viral immunotherapy will inspire future generations of scientists. His ongoing efforts to combat infectious diseases and promote healthier aging promise a lasting impact on global health and biotechnology.

Publication

  1. Title: Development of novel canine phage display-derived neutralizing monoclonal antibody fragments against rabies virus from immunized dogs
    Authors: A. Chorpunkul, U. Boonyuen, K. Limkittikul, P. Lekcharoensuk, P. Ramasoota
    Year: 2024

 

  1. Title: Characterization of Vibrio parahaemolyticus isolated from clinical specimens and oysters in Thailand
    Authors: N. Tewawong, S. Kowaboot, S. Kengkarn, P. Ramasoota, O. Suthienkul
    Year: 2024

 

  1. Title: Nicotiana benthamiana as a potential source for producing anti-dengue virus D54 neutralizing therapeutic antibody
    Authors: S. Krittanai, K. Rattanapisit, C.J.I. Bulaon, R. Strasser, W. Phoolcharoen
    Year: 2024

 

  1. Title: Associations of effort-reward imbalance at work and quality of life among workers after stroke: a one-year longitudinal study in Thailand
    Authors: S. Naknoi, J. Li, P. Ramasoota, N. Soonthornworasiri, O. Kaewboonchoo
    Year: 2023

 

  1. Title: Potential Protective Effect of Dengue NS1 Human Monoclonal Antibodies against Dengue and Zika Virus Infections
    Authors: R. Sootichote, W. Puangmanee, S. Benjathummarak, P. Ramasoota, P. Pitaksajjakul
    Year: 2023

 

  1. Title: A replication competent luciferase-secreting DENV2 reporter for sero-epidemiological surveillance of neutralizing and enhancing antibodies
    Authors: K. Saipin, B.K. Thaisomboonsuk, B. Siridechadilok, N. Sittisombut, J. Junjhon
    Year: 2022

 

  1. Title: Spread of a Novel Indian Ocean Lineage Carrying E1‐K211E/E2‐V264A of Chikungunya Virus East/Central/South African Genotype across the Indian Subcontinent, Southeast Asia, and Eastern Africa
    Authors: J. Phadungsombat, H.A. Imad, E.E. Nakayama, W. Piyaphanee, T. Shioda
    Year: 2022

 

🎯 Conclusion

Dr. Ramasoota’s work has not only advanced scientific knowledge but also contributed to real-world solutions in disease treatment and diagnostics. His collaborations with industries and commitment to innovation ensure that his research continues to benefit global health. As he continues to push the boundaries of antibody research and anti-aging science, his legacy will inspire future generations of scientists, leaving a lasting impact on virology, immunotherapy, and biotechnology.

 

John Vincent Sanchez Orti | Biomarkers in Neurocognition | Young Scientist Award

Dr. John Vincent Sanchez Orti | Biomarkers in Neurocognition | Young Scientist Award

Dr. Joan Vicent Sánchez Ortí, Health research institute,  Spain.

Joan Vicent Sánchez Ortí is a Clinical Psychologist and Neuropsychologist currently working as a Research Technician at the Instituto de Investigación Sanitaria – INCLIVA. He is also a predoctoral researcher affiliated with CIBERSAM (Group 24, Universitat de València). His academic background includes a Bachelor’s degree in Psychology (2016), a Master’s in General Health Psychology (2019), and a Master’s in Basic and Applied Neurosciences (2021), all from Universitat de València. He is currently pursuing a Ph.D. in Medicine.

Profile

Google Scholar

Orcid

🧠 A Passion for Understanding the Mind

Joan Vicent Sánchez Ortí was born on August 6, 1994, with an innate curiosity about the complexities of human cognition. From an early age, he displayed a deep interest in psychology and neuroscience, which led him to pursue an academic path dedicated to unraveling the mysteries of the brain. His journey began at the Universitat de València, where he obtained his degree in Psychology in 2016. Motivated by his growing fascination with neuropsychology, he continued his studies, earning a Master’s in General Health Psychology in 2019 and a Master’s in Basic and Applied Neurosciences in 2021. His dedication to advancing medical science led him to enroll in an official Doctorate Program in Medicine at the same institution.

🏥 Bridging Psychology and Neuroscience in Professional Practice

Currently serving as a Neuropsychologist and Research Technician at the Health Research Institute (INCLIVA) in Spain, Joan Vicent plays a vital role in understanding cognitive impairments associated with severe mental disorders. His affiliation with the Biomedical Research Center in Mental Health Network (CIBERSAM) – Group 24 at the Universitat de València has allowed him to contribute significantly to groundbreaking studies. His expertise lies in assessing neurocognitive deficits, biomarkers, and epigenetic factors, aiming to enhance the diagnosis and treatment of psychiatric and neurological conditions.

🔬 Advancing Research in Neurocognitive Deficits and Mental Health

Joan Vicent’s research delves into the intricate connections between brain function, cognition, and mental health. His studies focus on identifying early biomarkers of cognitive decline, exploring epigenetic influences, and evaluating social functioning and quality of life in patients suffering from severe mental disorders. His contributions have been instrumental in improving the understanding of conditions such as schizophrenia, bipolar disorder, and neurodegenerative diseases, providing valuable insights for clinical interventions.

🏆 Recognized for Excellence in Neuroscience and Psychology

Through his commitment to scientific discovery, Joan Vicent has garnered recognition in the field of neuroscience and psychology. His contributions to neuropsychology and mental health research have positioned him as a promising figure in cognitive science. His work is widely acknowledged for its impact on the development of new therapeutic approaches and diagnostic techniques. With a strong academic and research background, he continues to be an influential voice in the study of cognitive impairment.

🌍 Impacting Lives Through Mental Health Research

Beyond academic achievements, Joan Vicent’s work has real-world implications, improving the quality of life for individuals facing cognitive challenges. His research contributes to developing more effective treatments, enhancing diagnostic accuracy, and fostering a better understanding of mental disorders. Through his role at INCLIVA and CIBERSAM, he actively collaborates with interdisciplinary teams, ensuring that his findings are translated into clinical practice, ultimately benefiting patients and healthcare professionals alike.

🚀 Paving the Way for Future Innovations in Neuropsychology

With a strong foundation in psychology, neuroscience, and medicine, Joan Vicent remains dedicated to pushing the boundaries of cognitive research. His ongoing studies aim to integrate cutting-edge techniques in neuroimaging, genetics, and artificial intelligence to refine the understanding of neurocognitive disorders. His ambition is to contribute to the development of personalized medicine, where treatments are tailored to an individual’s neurobiological and psychological profile, revolutionizing mental healthcare.

🔮 A Vision for a Healthier, Cognitively Resilient Future

Looking ahead, Joan Vicent Sánchez Ortí envisions a world where mental health is better understood, diagnosed, and treated with precision. His dedication to neuropsychology and cognitive research will continue to shape the future of mental healthcare, inspiring new generations of scientists and clinicians. As he advances in his career, his unwavering commitment to improving lives through research stands as a testament to his passion and perseverance in the field of neuroscience.

Publication

  • Manual motor speed dysfunction as a neurocognitive endophenotype in euthymic bipolar disorder patients and their healthy relatives. Evidence from a 5-year follow-up study
    P Correa-Ghisays, V Balanzá-Martínez, G Selva-Vera, J Vila-Francés, …
    2017

 

  • Grip Strength, Neurocognition, and social functioning in people With Type-2 diabetes mellitus, major depressive disorder, bipolar disorder, and schizophrenia
    M Aliño-Dies, JV Sanchez-Orti, P Correa-Ghisays, V Balanzá-Martinez, …
    2020

 

  • Visual memory dysfunction as a neurocognitive endophenotype in bipolar disorder patients and their unaffected relatives. Evidence from a 5-year follow-up Valencia study
    P Correa-Ghisays, JV Sánchez-Ortí, R Ayesa-Arriola, E Setién-Suero, …
    2019

 

  • Specific metabolic syndrome components predict cognition and social functioning in people with type 2 diabetes mellitus and severe mental disorders
    JV Sanchez‐Orti, V Balanzá‐Martinez, P Correa‐Ghisays, G Selva‐Vera, …
    2022

 

  • Immune–Inflammatory Biomarkers Predict Cognition and Social Functioning in Patients With Type 2 Diabetes Mellitus, Major Depressive Disorder, Bipolar Disorder, and …
    M Garés-Caballer, JV Sánchez-Ortí, P Correa-Ghisays, …
    2022

 

  • Probiotic, prebiotic, synbiotic and fermented food supplementation in psychiatric disorders: A systematic review of clinical trials
    C Ribera, JV Sánchez-Ortí, G Clarke, W Marx, S Mörkl, …
    2024

 

  • Transdiagnostic neurocognitive deficits in patients with type 2 diabetes mellitus, major depressive disorder, bipolar disorder, and schizophrenia: A 1-year follow-up study
    P Correa-Ghisays, JV Sanchez-Orti, V Balanza-Martinez, G Selva-Vera, …
    2022

 

  • Inflammation and lipid metabolism as potential biomarkers of memory impairment across type 2 diabetes mellitus and severe mental disorders
    JV Sanchez-Orti, P Correa-Ghisays, V Balanza-Martinez, G Selva-Vera, …
    2023

 

  • MICEmi: A method to identify cognitive endophenotypes of mental illnesses
    P Correa-Ghisays, JV Sanchez-Orti, V Balanza-Martinez, I Fuentes-Dura, …
    2022

 

  • Specific immune-inflammatory profiles and neurocognitive deficits predict illness trajectories in people with type 2 diabetes mellitus or psychiatric disorders
    JV Sanchez-Orti, P Correa-Ghisays, V Balanza-Martinez, G Selva-Vera, …
    2025

 

Conclusion 🎯

Joan Vicent Sánchez Ortí’s dedication to neuroscience and mental health research positions him as an influential figure in the field. His expertise bridges psychology, medicine, and genetics, offering innovative solutions for cognitive disorders. With a strong commitment to improving lives through research, his work has already made a meaningful impact and will continue to shape the future of mental healthcare, neuropsychology, and personalized medicine. As he advances in his career, his passion and contributions will undoubtedly lead to groundbreaking discoveries in cognitive science.

Shilin Luo | Neurogenetics and Molecular Neuroscience | Best Researcher Award

Prof. Shilin Luo | Neurogenetics and Molecular Neuroscience | Best Researcher Award

Prof. Shilin Luo, Xiangya Hospital, Central South University, China.

Dr. Shilin Luo is a leading expert in neuropharmacology and medicinal chemistry, with a strong academic background in traditional Chinese medicine and modern pharmacology. His research focuses on the pathogenesis of neurodegenerative diseases and the development of innovative drug therapies. Through his work at Xiangya Hospital, Central South University, and previous research at Emory University, he has made significant contributions to understanding neurological disorders. His studies on animal models and risk genes have paved the way for novel treatment strategies, earning him international recognition.

Profile

Scopus

Orcid

 

🎓 Early Academic Pursuits

Dr. Shilin Luo’s journey into the world of medical science began with a deep-rooted passion for understanding the complexities of neurological diseases. He earned his Bachelor’s degree in Chinese Materia Medica from Shenyang Pharmaceutical University, where he developed a strong foundation in traditional Chinese medicine and pharmacology. With an insatiable thirst for knowledge, he further pursued a Ph.D. in Medicinal Chemistry at China Pharmaceutical University, specializing in the research of active ingredients in natural products. Under the mentorship of Prof. Wencai Ye, a distinguished scholar, Dr. Luo honed his expertise in medicinal chemistry, paving the way for groundbreaking discoveries in neuropharmacology.

👨‍🎓 Professional Endeavors

To deepen his expertise, Dr. Luo embarked on postdoctoral research at Emory University’s School of Medicine in the Department of Pathology and Laboratory Medicine. Working under the esteemed Prof. Keqiang Ye, he focused on neurobiology and neuropharmacology, contributing significantly to the understanding of neurodegenerative diseases. His research provided novel insights into the molecular mechanisms underlying neurological disorders, positioning him as a leading figure in the field. He later took on a pivotal role as a professor in the Department of Neurology at Xiangya Hospital, Central South University, where he continues to mentor young scientists and advance medical research.

🧪 Contributions and Research Focus

Dr. Luo’s research is primarily dedicated to uncovering the pathogenesis of neurodegenerative diseases and developing therapeutic interventions. His work in animal models of pathogenic and risk genes for neurological disorders has been instrumental in identifying potential drug targets. By integrating traditional Chinese medicine with modern pharmacology, he has contributed to the development of innovative neuroprotective agents. His studies on the molecular mechanisms of neuronal degeneration have led to promising advancements in combating conditions such as Alzheimer’s and Parkinson’s disease.

🏆 Accolades and Recognition

Throughout his career, Dr. Luo has been widely recognized for his groundbreaking contributions to neuropharmacology. His research has been published in high-impact scientific journals, earning him international acclaim. His dedication to scientific excellence has garnered prestigious awards, and he is frequently invited to deliver keynote lectures at global conferences. His work continues to inspire fellow researchers, solidifying his reputation as a distinguished scientist in neurological drug development.

🏰 Impact and Influence

Dr. Luo’s impact extends beyond the laboratory, as he actively contributes to the medical community through mentorship and collaboration. His efforts in integrating traditional Chinese medicinal principles with cutting-edge pharmacological approaches have opened new avenues for drug discovery. His research findings have not only influenced academic discourse but have also laid the groundwork for potential clinical applications, bringing hope to patients suffering from neurodegenerative diseases.

⚛️ Legacy and Future Contributions

As a visionary scientist, Dr. Luo continues to push the boundaries of neurological research. His commitment to translational medicine aims to bridge the gap between laboratory discoveries and clinical applications. By fostering interdisciplinary collaborations and mentoring the next generation of researchers, he is shaping the future of neuropharmacology.

 

Publication

  • Disease-modifying therapies for Alzheimer’s disease: Clinical trial progress and opportunity
    Authors: Yujie Zhang, Jie Chen, Yanru Li, Bin Jiao, Shilin Luo
    Year: 2025

 

  • The role of the probiotic Akkermansia muciniphila in brain functions: insights underpinning therapeutic potential
    Authors: Ruiling Xu, Yuxuan Zhang, Shurui Chen, Yaohui Zeng, Xuan Fu, Ti Chen, Shilin Luo, Xiaojie Zhang
    Year: 2023

 

  • Nonviral delivery systems for antisense oligonucleotide therapeutics
    Authors: Si Huang, Xin-Yan Hao, Yong-Jiang Li, Jun‑Yong Wu, Da-Xiong Xiang, Shilin Luo
    Year: 2022

 

  • The Microglial membrane receptor TREM2 mediates exosome secretion to promote phagocytosis of amyloid‐β by microglia
    Authors: Si Huang, Xiaoli Liao, Junyong Wu, Xiaojie Zhang, Yamin Li, Daxiong Xiang, Shilin Luo
    Year: 2022

 

  • Correction: Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine
    Authors: Not explicitly listed
    Year: 2021

 

  • Polygonatum sibiricum Polysaccharides Protect against MPP‐Induced Neurotoxicity via the Akt/mTOR and Nrf2 Pathways
    Authors: Si Huang, Haiyan Yuan, Wenqun Li, Xinyi Liu, Xiaojie Zhang, Daxiong Xiang, Shilin Luo, Guodong Zhang
    Year: 2021

 

  • Bushen-Tiansui Formula Improves Cognitive Functions in an Aβ1–42 Fibril-Infused Rat Model of Alzheimer’s Disease
    Authors: Chenxia Sheng, Panpan Xu, Xinyi Liu, Weijun Peng, Daxiong Xiang, Shilin Luo
    Year: 2020

 

  • Osteogenesis activity of isocoumarin a through the activation of the PI3K-Akt/Erk cascade-activated BMP/RUNX2 signaling pathway
    Authors: Not explicitly listed
    Year: 2019

 

  • Akt Phosphorylates NQO1 and Triggers its Degradation, Abolishing Its Antioxidative Activities in Parkinson’s Disease
    Authors: Shilin Luo, Seong Su Kang, Zhi-Hao Wang, Xia Liu, Julia X Day, Zhiping Wu, Junmin Peng, Daxiong Xiang, Wolfdieter Springer, Keqiang Ye
    Year: 2019

 

  • Puerarin-loaded PEG-PE micelles with enhanced anti-apoptotic effect and better pharmacokinetic profile
    Authors: Not explicitly listed
    Year: 2018

 

Conclusion

Dr. Luo’s unwavering dedication to neurological research continues to shape the future of neuropharmacology. His innovative approach, combining traditional medicinal insights with modern scientific advancements, has the potential to revolutionize drug development for neurodegenerative diseases. As a mentor, researcher, and pioneer in his field, his contributions will leave a lasting impact on both academia and clinical medicine, offering hope for more effective treatments in the years to come.

 

Hiroshi Yamada | Neuroscience | Excellence in Innovation

Mr. Hiroshi Yamada | Neuroscience | Excellence in Innovation

Mr. Hiroshi Yamada, Medical/Tsukuba, Japan.

H. Yamada, born in Kasugai, Aichi, Japan, has built an impressive academic and professional career in neuroscience. After earning his Bachelor of Science from Tohoku University, he pursued a Master’s degree at Osaka University and later obtained his Ph.D. from Kyoto Prefectural University of Medicine. His research journey took him from postdoctoral studies in Japan to New York University, where he collaborated with renowned neuroscientist Paul W. Glimcher. Returning to Japan, he served as Section Chief at the National Center of Neurology and Psychiatry before joining the University of Tsukuba, where he progressed from Assistant Professor to Associate Professor. His research focuses on neural mechanisms, contributing significantly to neuroscience through both theoretical and practical advancements.

Profile

Google Scholar

🎓 Early Academic Pursuits

H. Yamada’s academic journey reflects a deep-rooted passion for science and medicine. Born on September 9, 1977, in Kasugai, Aichi, Japan, he pursued a Bachelor of Science degree from the Faculty of Science at Tohoku University, graduating in 2000. Driven by a desire to deepen his understanding of human biology, he earned his Master of Arts from the Faculty of Medicine at Osaka University in 2002. His academic pursuits culminated in a Ph.D. from the Graduate School of Kyoto Prefectural University of Medicine in 2005, where he laid the groundwork for his future research in neuroscience.

🧠 Professional Endeavors in Neuroscience

H. Yamada’s professional career began with postdoctoral research at Kyoto Prefectural University of Medicine under the mentorship of Minoru Kimura, focusing on advanced neurological studies. His pursuit of global scientific exposure led him to New York University in 2008, where he worked with renowned neuroscientist Paul W. Glimcher. Upon returning to Japan, Yamada took on a leadership role as Section Chief at the National Center of Neurology and Psychiatry, National Institute of Neuroscience, from 2011. This role was pivotal in shaping his expertise in neurological research, ultimately leading to his tenure as Assistant Professor at the University of Tsukuba in 2013, and later as Associate Professor in 2022.

🔬 Contributions and Research Focus

Throughout his career, H. Yamada has been dedicated to unraveling the complexities of the human brain. His research primarily focuses on neuroscience, exploring neural mechanisms underlying behavior and cognition. At the University of Tsukuba, he has contributed significantly to the understanding of brain functions, merging experimental data with theoretical models to advance the field. His collaborations with international experts have enriched his approach, making his work both diverse and impactful.

🏅 Accolades and Recognition

Yamada’s contributions to neuroscience have earned him recognition within the academic community. His leadership roles and tenured position at the University of Tsukuba reflect his outstanding research and teaching capabilities. His work at prestigious institutions like New York University and the National Center of Neurology and Psychiatry has further solidified his reputation as a respected neuroscientist, contributing to both national and international scientific advancements.

🌍 Impact and Influence

H. Yamada’s research has had a profound impact on the field of neuroscience, influencing both academic circles and clinical practices. His studies on neural behavior have provided insights that bridge the gap between theoretical neuroscience and practical applications, aiding in the development of treatments for neurological disorders. As an educator, he has mentored numerous students, fostering the next generation of neuroscientists.

🚀 Legacy and Future Contributions

Looking ahead, H. Yamada is committed to expanding the horizons of neuroscience through innovative research and global collaborations. His legacy is not only reflected in his published work but also in the students and researchers he has inspired. As he continues his journey at the University of Tsukuba, his focus remains on advancing scientific knowledge and contributing to the global understanding of the human brain.

💡 A Lifelong Dedication to Science

H. Yamada’s life is a testament to the power of curiosity and dedication. From his early academic days in Tohoku to his current role as an Associate Professor, he has consistently pursued excellence in neuroscience. His journey underscores the importance of interdisciplinary research, mentorship, and the relentless quest for knowledge, leaving a lasting mark on the scientific community.

Publication

  • Title: Tonically active neurons in the primate caudate nucleus and putamen differentially encode instructed motivational outcomes of action
    Authors: H. Yamada, N. Matsumoto, M. Kimura
    Year: 2004

 

  • Title: Roles of the lateral habenula and anterior cingulate cortex in negative outcome monitoring and behavioral adjustment in nonhuman primates
    Authors: T. Kawai, H. Yamada, N. Sato, M. Takada, M. Matsumoto
    Year: 2015

 

  • Title: Thirst-dependent risk preferences in monkeys identify a primitive form of wealth
    Authors: H. Yamada, A. Tymula, K. Louie, P.W. Glimcher
    Year: 2013

 

  • Title: Juxtacellular labeling of tonically active neurons and phasically active neurons in the rat striatum
    Authors: H. Inokawa, H. Yamada, N. Matsumoto, M. Muranishi, M. Kimura
    Year: 2010

 

  • Title: Free choice shapes normalized value signals in medial orbitofrontal cortex
    Authors: H. Yamada, K. Louie, A. Tymula, P.W. Glimcher
    Year: 2018

 

  • Title: Tonically active neurons in the striatum encode motivational contexts of action
    Authors: M. Kimura, H. Yamada, N. Matsumoto
    Year: 2003

 

  • Title: Tonic firing mode of midbrain dopamine neurons continuously tracks reward values changing moment-by-moment
    Authors: Y. Wang, O. Toyoshima, J. Kunimatsu, H. Yamada, M. Matsumoto
    Year: 2021

 

  • Title: Roles of centromedian parafascicular nuclei of thalamus and cholinergic interneurons in the dorsal striatum in associative learning of environmental events
    Authors: K. Yamanaka, Y. Hori, T. Minamimoto, H. Yamada, N. Matsumoto, et al.
    Year: 2018

 

  • Title: Inactivation of the putamen selectively impairs reward history-based action selection
    Authors: M. Muranishi, H. Inokawa, H. Yamada, Y. Ueda, N. Matsumoto, M. Nakagawa, et al.
    Year: 2011

 

  • Title: Goal-directed, serial and synchronous activation of neurons in the primate striatum
    Authors: M. Kimura, N. Matsumoto, K. Okahashi, Y. Ueda, T. Satoh, T. Minamimoto, et al.
    Year: 2003

 

Conclusion

H. Yamada’s career is a reflection of his dedication to advancing the understanding of the human brain. His academic achievements, leadership roles, and research contributions have left a lasting impact on the neuroscience community. As he continues his work at the University of Tsukuba, his legacy is defined not only by his scientific discoveries but also by his mentorship and influence on future generations of researchers. His journey stands as an inspiring example of the pursuit of knowledge and the transformative power of science.